GlassScriptPhysician profile
Gina Garrett Licause
NPI 1699762039
$1,486.91
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,248 · 2020: $239.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $317.62 | 2019-2020 | |
| Pfizer INC. | $143.16 | 2019-2020 | |
| Novo Nordisk INC | $140.74 | 2019 | |
| Daiichi Sankyo INC. | $105.22 | 2019 | |
| Amgen INC. | $93.93 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $80.30 | 2019 | |
| Eisai INC. | $73.33 | 2019 | |
| Abbvie INC. | $61.45 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.22 | 2019-2020 | |
| Amarin Pharma, INC. | $54.38 | 2019-2020 | |
| Lilly USA, LLC | $48.82 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $43.03 | 2019 | |
| Astellas Pharma US INC | $40.86 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.43 | 2019 | |
| Genentech USA, INC. | $35.67 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $32.73 | 2019 | |
| Janssen Pharmaceuticals, INC | $30.94 | 2019-2020 | |
| Aytu Biopharma, INC. | $17.34 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.19 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $15.92 | 2019 | |
| Cranial Technologies, INC | $13.71 | 2019 | |
| Boston Scientific Corporation | $13.11 | 2019 | |
| Merck Sharp & Dohme LLC | $12.81 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gina Licause listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.